Health and economic impact of seasonal influenza mass vaccination strategies in European settings: A mathematical modelling and cost-effectiveness analysis.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Sandmann, Frank Gvan Leeuwen, Edwin
Bernard-Stoecklin, Sibylle
Casado, Itziar
Castilla, Jesús
Domegan, Lisa
Gherasim, Alin
Hooiveld, Mariëtte
Kislaya, Irina
Larrauri, Amparo
Levy-Bruhl, Daniel
Machado, Ausenda
Marques, Diogo F P
Martínez-Baz, Iván
Mazagatos, Clara
McMenamin, Jim
Meijer, Adam
Murray, Josephine L K
Nunes, Baltazar
O'Donnell, Joan
Reynolds, Arlene
Thorrington, Dominic
Pebody, Richard
Baguelin, Marc
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Health and economic impact of seasonal influenza mass vaccination strategies in European settings: A mathematical modelling and cost-effectiveness analysis.Published in
Vaccine 2022; 40(9):1306-15PMID
35109968ae974a485f413a2113503eed53cd6c53
10.1016/j.vaccine.2022.01.015
Scopus Count
Collections
Related articles
- Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands.
- Authors: de Boer PT, Nagy L, Dolk FCK, Wilschut JC, Pitman R, Postma MJ
- Issue date: 2021 Jan
- Assessing optimal use of the standard dose adjuvanted trivalent seasonal influenza vaccine in the elderly.
- Authors: Thorrington D, van Leeuwen E, Ramsay M, Pebody R, Baguelin M
- Issue date: 2019 Apr 3
- Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis.
- Authors: Lugnér AK, van Boven M, de Vries R, Postma MJ, Wallinga J
- Issue date: 2012 Jul 12
- Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany.
- Authors: Molnar D, Anastassopoulou A, Poulsen Nautrup B, Schmidt-Ott R, Eichner M, Schwehm M, Dos Santos G, Ultsch B, Bekkat-Berkani R, von Krempelhuber A, Van Vlaenderen I, Van Bellinghen LA
- Issue date: 2022 Nov 30
- Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England.
- Authors: Thorrington D, van Leeuwen E, Ramsay M, Pebody R, Baguelin M
- Issue date: 2017 Sep 8